Volume 24, Number 9—September 2018
Dispatch
Maripa Virus RNA Load and Antibody Response in Hantavirus Pulmonary Syndrome, French Guiana
Table 1
Immune response and viral loads on admission in 6 confirmed hantavirus cases, French Guiana*
Characteristic | Patient 1 | Patient 2 | Patient 3 | Patient 4 | Patient 5 | Patient 6 |
---|---|---|---|---|---|---|
Year case reported | 2008 | 2009 | 2010 | 2013 | 2016 | 2017 |
Age, y | 38 | 56 | 49 | 67 | 71 | 47 |
Days of disease at admission | 7 | 4 | 2 | 4 | 4 | 7 |
SNV IgM | Positive | Positive | Positive | Positive | Positive | Positive |
IgM sum OD† | 1.02 | 1.70 | 4.72 | 0.92 | 2.23 | 1.79 |
SNV IgG | Negative | Negative | Negative | Negative | Positive | Negative |
IgG sum OD† | 0.05 | 0.01 | 0.01 | 0.01 | 2.05 | 0.73 |
Serum viral RNA load‡ | 5.8 | 6.6 | 6.4 | 5.9 | 6.0 | 6.4 |
Clinical evolution | Favorable | Death | Death | Death | Death | Favorable |
*OD, optical density; SNV, Sin Nombre virus.
†Adjusted sum OD values (dilution 1:100, 1:400, 1:1,600, and 1:6,400).
‡Virus copy number was determined as log10 copies/mL. Primers and TaqMan probe for quantitative PCR were Maripa_qRT2F 5'-GCAGCTGTGTCTACATTGGAGAA-3', Maripa_qRT2R 5'-CCACCAGATCCGCCAACT-3', and Maripa_Probe2 5'-FAM-AAACTTGCAGAACTCA-MGB-3'.
Page created: August 15, 2018
Page updated: August 15, 2018
Page reviewed: August 15, 2018
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.